The Association Between Thromboembolic Complications and Blood Group in Patients With Atrial Fibrillation

Blood group O may be protective against peripheral cardioembolic complications of NVAF, which may relate, in part, to reduced circulating von Willebrand factor levels. Cerebral thromboembolic event rates did not differ by blood group.